Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Efficacy of TAP and ESP Blocks for Postoperative Analgesia After Elective Cesarean Section
NCT07853482Not yet recruiting
- Sponsor
- Taganrog Maternity Hospital
- Start
- Oct 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by Taganrog Maternity Hospital. Primary endpoint: Intensity of visceral pain at 16 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07853482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07853482.